{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:46:42Z","timestamp":1788378402653,"version":"build-2803163510"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Scholarship Council grant","award":["202208340021"],"award-info":[{"award-number":["202208340021"]}]},{"name":"vzw Kinderkankerfonds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00277-025-06616-3","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T06:44:27Z","timestamp":1758177867000},"page":"4333-4345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prime-time for LncRNA signatures in acute myeloid leukemia?"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7598-9584","authenticated-orcid":false,"given":"Zhiyao","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2449-539X","authenticated-orcid":false,"given":"Barbara","family":"De Moerloose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-4027","authenticated-orcid":false,"given":"Tim","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"6616_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ (2021) Advances in acute myeloid leukemia. BMJ 375:n2026. https:\/\/doi.org\/10.1136\/bmj.n2026","journal-title":"BMJ"},{"key":"6616_CR2","unstructured":"SEER data base Cancer Stat Facts: Leukemia \u2014 Acute Myeloid Leukemia (AML) [Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html"},{"issue":"12","key":"6616_CR3","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Ravandi F, Kadia TM, DiNardo CD, Short NJ, Borthakur G et al (2021) De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer 127(12):2049\u201361. https:\/\/doi.org\/10.1002\/cncr.33458","journal-title":"Cancer"},{"issue":"1","key":"6616_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/jcm4010127","volume":"4","author":"JD de Rooij","year":"2015","unstructured":"de Rooij JD, Zwaan CM, van den Heuvel-Eibrink M (2015) Pediatric AML: from biology to clinical management. J Clin Med 4(1):127\u2013149. https:\/\/doi.org\/10.3390\/jcm4010127","journal-title":"J Clin Med"},{"issue":"9","key":"6616_CR5","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3324\/haematol.2022.281106","volume":"108","author":"G Egan","year":"2023","unstructured":"Egan G, Tasian SK (2023) Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023. Haematologica 108(9):2275\u20132288. https:\/\/doi.org\/10.3324\/haematol.2022.281106","journal-title":"Haematologica"},{"issue":"18","key":"6616_CR6","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1200\/JCO.23.01841","volume":"42","author":"A Tierens","year":"2024","unstructured":"Tierens A, Arad-Cohen N, Cheuk D, De Moerloose B, Fernandez Navarro JM, Hasle H et al (2024) Mitoxantrone versus liposomal daunorubicin in induction of pediatric AML with risk stratification based on flow cytometry measurement of residual disease. J Clin Oncol 42(18):2174\u20132185. https:\/\/doi.org\/10.1200\/JCO.23.01841","journal-title":"J Clin Oncol"},{"key":"6616_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133512","author":"E Boscaro","year":"2023","unstructured":"Boscaro E, Urbino I, Catania FM, Arrigo G, Secreto C, Olivi M et al (2023) Modern risk stratification of acute myeloid leukemia in 2023: integrating established and emerging prognostic factors. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15133512","journal-title":"Cancers (Basel)"},{"issue":"5","key":"6616_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27605","volume":"66","author":"B De Moerloose","year":"2019","unstructured":"De Moerloose B, Reedijk A, de Bock GH, Lammens T, de Haas V, Denys B et al (2019) Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: results from protocol DB AML-01. Pediatr Blood Cancer 66(5):e27605. https:\/\/doi.org\/10.1002\/pbc.27605","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"6616_CR9","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00277-022-04965-x","volume":"101","author":"R Masetti","year":"2022","unstructured":"Masetti R, Muratore E, Gori D, Prete A, Locatelli F (2022) Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis. Ann Hematol 101(11):2497\u20132506. https:\/\/doi.org\/10.1007\/s00277-022-04965-x","journal-title":"Ann Hematol"},{"issue":"3","key":"6616_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM (2023) Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 98(3):502\u201326. https:\/\/doi.org\/10.1002\/ajh.26822","journal-title":"Am J Hematol"},{"issue":"2","key":"6616_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12185-023-03533-x","volume":"117","author":"N Shiba","year":"2023","unstructured":"Shiba N (2023) Comprehensive molecular understanding of pediatric acute myeloid leukemia. Int J Hematol 117(2):173\u2013181. https:\/\/doi.org\/10.1007\/s12185-023-03533-x","journal-title":"Int J Hematol"},{"issue":"1","key":"6616_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17(1):47\u201362. https:\/\/doi.org\/10.1038\/nrg.2015.10","journal-title":"Nat Rev Genet"},{"issue":"8","key":"6616_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.tig.2024.04.009","volume":"40","author":"AM Habib","year":"2024","unstructured":"Habib AM, Cox JJ, Okorokov AL (2024) Out of the dark: the emerging roles of lncRNAs in pain. Trends Genet 40(8):694\u2013705. https:\/\/doi.org\/10.1016\/j.tig.2024.04.009","journal-title":"Trends Genet"},{"issue":"5","key":"6616_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","volume":"21","author":"RW Yao","year":"2019","unstructured":"Yao RW, Wang Y, Chen LL (2019) Cellular functions of long noncoding RNAs. Nat Cell Biol 21(5):542\u2013551. https:\/\/doi.org\/10.1038\/s41556-019-0311-8","journal-title":"Nat Cell Biol"},{"issue":"12","key":"6616_CR15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.tcb.2018.06.001","volume":"28","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Gao S, Xia J, Liu F (2018) Hematopoietic hierarchy - an updated roadmap. Trends Cell Biol 28(12):976\u2013986. https:\/\/doi.org\/10.1016\/j.tcb.2018.06.001","journal-title":"Trends Cell Biol"},{"issue":"4","key":"6616_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/CM9.0000000000000624","volume":"133","author":"FY Wang","year":"2020","unstructured":"Wang FY, Gu ZY, Gao CJ (2020) Emerging role of long non-coding RNAs in normal and malignant hematopoiesis. Chin Med J (Engl) 133(4):462\u2013473. https:\/\/doi.org\/10.1097\/CM9.0000000000000624","journal-title":"Chin Med J (Engl)"},{"issue":"31","key":"6616_CR17","doi-asserted-by":"publisher","first-page":"50666","DOI":"10.18632\/oncotarget.9308","volume":"7","author":"L Nobili","year":"2016","unstructured":"Nobili L, Lionetti M, Neri A (2016) Long non-coding RNAs in normal and malignant hematopoiesis. Oncotarget 7(31):50666\u201350681. https:\/\/doi.org\/10.18632\/oncotarget.9308","journal-title":"Oncotarget"},{"issue":"4","key":"6616_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cell.2013.01.034","volume":"152","author":"E Yildirim","year":"2013","unstructured":"Yildirim E, Kirby JE, Brown DE, Mercier FE, Sadreyev RI, Scadden DT et al (2013) Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 152(4):727\u201342. https:\/\/doi.org\/10.1016\/j.cell.2013.01.034","journal-title":"Cell"},{"issue":"24","key":"6616_CR19","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1101\/gad.178780.111","volume":"25","author":"W Hu","year":"2011","unstructured":"Hu W, Yuan B, Flygare J, Lodish HF (2011) Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev 25(24):2573\u20132578. https:\/\/doi.org\/10.1101\/gad.178780.111","journal-title":"Genes Dev"},{"issue":"18","key":"6616_CR20","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/blood-2017-06-788695","volume":"130","author":"JR Alvarez-Dominguez","year":"2017","unstructured":"Alvarez-Dominguez JR, Lodish HF (2017) Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis. Blood 130(18):1965\u201375. https:\/\/doi.org\/10.1182\/blood-2017-06-788695","journal-title":"Blood"},{"issue":"2","key":"6616_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cr.2018.08.001","volume":"7","author":"W Li","year":"2018","unstructured":"Li W, Ren Y, Si Y, Wang F, Yu J (2018) Long non-coding RNAs in hematopoietic regulation. Cell Regen 7(2):27\u201332. https:\/\/doi.org\/10.1016\/j.cr.2018.08.001","journal-title":"Cell Regen"},{"key":"6616_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111638","author":"M Gourvest","year":"2019","unstructured":"Gourvest M, Brousset P, Bousquet M (2019) Long noncoding RNAs in acute myeloid leukemia: functional characterization and clinical relevance. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11111638","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6616_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40348-022-00142-2","volume":"9","author":"S Neyazi","year":"2022","unstructured":"Neyazi S, Ng M, Heckl D, Klusmann JH (2022) Long noncoding RNAs as regulators of pediatric acute myeloid leukemia. Mol Cell Pediatr 9(1):10. https:\/\/doi.org\/10.1186\/s40348-022-00142-2","journal-title":"Mol Cell Pediatr"},{"issue":"52","key":"6616_CR24","doi-asserted-by":"publisher","first-page":"18679","DOI":"10.1073\/pnas.1422050112","volume":"111","author":"R Garzon","year":"2014","unstructured":"Garzon R, Volinia S, Papaioannou D, Nicolet D, Kohlschmidt J, Yan P et al (2014) Expression and prognostic impact of LncRNAs in acute myeloid leukemia. Proc Natl Acad Sci U S A 111(52):18679\u201318684. https:\/\/doi.org\/10.1073\/pnas.1422050112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6616_CR25","doi-asserted-by":"publisher","unstructured":"Vanhooren J, Van Camp L, Depreter B, de Jong M, Uyttebroeck A, Van Damme A et al (2022) Deciphering the non-coding RNA landscape of pediatric acute myeloid leukemia. Cancers (Basel) 14(9). https:\/\/doi.org\/10.3390\/cancers14092098","DOI":"10.3390\/cancers14092098"},{"key":"6616_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0808-z","volume":"19","author":"SL Wang","year":"2019","unstructured":"Wang SL, Huang Y, Su R, Yu YY (2019) Silencing long non-coding RNA HOTAIR exerts anti-oncogenic effect on human acute myeloid leukemia via demethylation of HOXA5 by inhibiting Dnmt3b. Cancer Cell Int 19:114. https:\/\/doi.org\/10.1186\/s12935-019-0808-z","journal-title":"Cancer Cell Int"},{"issue":"12","key":"6616_CR27","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1002\/ijc.28922","volume":"135","author":"H Wang","year":"2014","unstructured":"Wang H, Li W, Guo R, Sun J, Cui J, Wang G et al (2014) An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies. Int J Cancer 135(12):2783\u20132794. https:\/\/doi.org\/10.1002\/ijc.28922","journal-title":"Int J Cancer"},{"key":"6616_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108720","volume":"112","author":"N Hu","year":"2019","unstructured":"Hu N, Chen L, Wang C, Zhao H (2019) MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells. Biomed Pharmacother 112:108720. https:\/\/doi.org\/10.1016\/j.biopha.2019.108720","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"6616_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03767-9","volume":"12","author":"Y Tao","year":"2021","unstructured":"Tao Y, Zhang J, Chen L, Liu X, Yao M, Zhang H (2021) LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p\/PBX3 signaling circuit. Cell Death Dis 12(6):510.10.1038\/s41419-021-03767-9","journal-title":"Cell Death Dis"},{"issue":"1","key":"6616_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22095-2","volume":"12","author":"G Zhu","year":"2021","unstructured":"Zhu G, Luo H, Feng Y, Guryanova OA, Xu J, Chen S et al (2021) Hoxblinc long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia. Nat Commun 12(1):1956. https:\/\/doi.org\/10.1038\/s41467-021-22095-2","journal-title":"Nat Commun"},{"issue":"2","key":"6616_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ (2021) Lncrna-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun 41(2):109\u201320. https:\/\/doi.org\/10.1002\/cac2.12108","journal-title":"Cancer Commun"},{"key":"6616_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114807","volume":"163","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Shu X, Chai Y, Liu W, Li Z, Xi Y (2023) The non-coding competing endogenous RNAs in acute myeloid leukemia: biological and clinical implications. Biomed Pharmacother 163:114807. https:\/\/doi.org\/10.1016\/j.biopha.2023.114807","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"6616_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY (2016) Long noncoding RNAs in cancer pathways. Cancer Cell 29(4):452\u201363. https:\/\/doi.org\/10.1016\/j.ccell.2016.03.010","journal-title":"Cancer Cell"},{"issue":"1","key":"6616_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41698-022-00283-7","volume":"6","author":"C Badowski","year":"2022","unstructured":"Badowski C, He B, Garmire LX (2022) Blood-derived LncRNAs as biomarkers for cancer diagnosis: the good, the bad and the beauty. NPJ Precis Oncol 6(1):40\u2013101038s41698","journal-title":"NPJ Precis Oncol"},{"issue":"7569","key":"6616_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature14906","volume":"525","author":"F Lai","year":"2015","unstructured":"Lai F, Gardini A, Zhang A, Shiekhattar R (2015) Integrator mediates the biogenesis of enhancer RNAs. Nature 525(7569):399\u2013403. https:\/\/doi.org\/10.1038\/nature14906","journal-title":"Nature"},{"key":"6616_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050480","author":"JK Kulski","year":"2019","unstructured":"Kulski JK (2019) Long noncoding RNA HCP5, a hybrid HLA class I endogenous retroviral gene: structure, expression, and disease associations. Cells. https:\/\/doi.org\/10.3390\/cells8050480","journal-title":"Cells"},{"issue":"1","key":"6616_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13867-2","volume":"7","author":"SE Jimenez-Badillo","year":"2017","unstructured":"Jimenez-Badillo SE, Oviedo N, Hernandez-Guzman C, Gonzalez-Mariscal L, Hernandez-Sanchez J (2017) Catsper1 promoter is bidirectional and regulates the expression of a novel lncRNA. Sci Rep 7(1):13351. https:\/\/doi.org\/10.1038\/s41598-017-13867-2","journal-title":"Sci Rep"},{"issue":"1","key":"6616_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/s0302-2838(03)00201-x","volume":"44","author":"D Hessels","year":"2003","unstructured":"Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B et al (2003) DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 44(1):8\u201315. https:\/\/doi.org\/10.1016\/s0302-2838(03)00201-x. discussion \u2013\u20096","journal-title":"Eur Urol"},{"issue":"13","key":"6616_CR39","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/S1470-2045(14)71113-1","volume":"15","author":"JR Prensner","year":"2014","unstructured":"Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM et al (2014) RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Lancet Oncol 15(13):1469\u201380. https:\/\/doi.org\/10.1016\/S1470-2045(14)71113-1","journal-title":"Lancet Oncol"},{"key":"6616_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.681867","volume":"12","author":"C Zhao","year":"2021","unstructured":"Zhao C, Wang Y, Tu F, Zhao S, Ye X, Liu J et al (2021) A prognostic autophagy-related long non-coding RNA (ARlncRNA) signature in acute myeloid leukemia (AML). Front Genet 12:681867. https:\/\/doi.org\/10.3389\/fgene.2021.681867","journal-title":"Front Genet"},{"issue":"1","key":"6616_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05148-9","volume":"24","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, He J, Li Z, Yang W (2023) Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia. BMC Bioinformatics 24(1):37. https:\/\/doi.org\/10.1186\/s12859-023-05148-9","journal-title":"BMC Bioinformatics"},{"key":"6616_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.966920","volume":"12","author":"P Li","year":"2022","unstructured":"Li P, Li J, Wen F, Cao Y, Luo Z, Zuo J et al (2022) A novel cuproptosis-related LncRNA signature: prognostic and therapeutic value for acute myeloid leukemia. Front Oncol 12:966920. https:\/\/doi.org\/10.3389\/fonc.2022.966920","journal-title":"Front Oncol"},{"issue":"5","key":"6616_CR43","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.21037\/tcr-22-2526","volume":"12","author":"T Zhang","year":"2023","unstructured":"Zhang T, Liao D, Hu Y (2023) Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia. Transl Cancer Res 12(5):1175\u201395. https:\/\/doi.org\/10.21037\/tcr-22-2526","journal-title":"Transl Cancer Res"},{"issue":"12","key":"6616_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22532","volume":"9","author":"C Cao","year":"2023","unstructured":"Cao C, Wang T, Luo Y, Zhang Y, Dai YY, Shen Y (2023) Comprehensive analysis of cuproptosis-associated LncRNAs predictive value and related CeRNA network in acute myeloid leukemia. Heliyon 9(12):e22532. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22532","journal-title":"Heliyon"},{"issue":"1","key":"6616_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2231737","volume":"28","author":"Q Wang","year":"2023","unstructured":"Wang Q (2023) Five cuprotosis-related lncRNA signatures for prognosis prediction in acute myeloid leukaemia. Hematology 28(1):2231737. https:\/\/doi.org\/10.1080\/16078454.2023.2231737","journal-title":"Hematology"},{"issue":"1","key":"6616_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-01085-9","volume":"14","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Wu W, Lin Z, Liu S, Chen Q, Jiang X et al (2021) Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia. BMC Med Genomics 14(1):236. https:\/\/doi.org\/10.1186\/s12920-021-01085-9","journal-title":"BMC Med Genomics"},{"key":"6616_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1218276","volume":"14","author":"F Ge","year":"2023","unstructured":"Ge F, Wang Y, Sharma A, Jaehde U, Essler M, Schmid M et al (2023) Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acute myeloid leukemia patients. Front Genet 14:1218276. https:\/\/doi.org\/10.3389\/fgene.2023.1218276","journal-title":"Front Genet"},{"issue":"12","key":"6616_CR48","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.21037\/tcr-23-429","volume":"12","author":"KY Xie","year":"2023","unstructured":"Xie KY, Chen SZ, Wang Y, Zeng ML, Liu XY, Liang Y et al (2023) Establishment and validation of a prognostic immune-related lncRNA risk model for acute myeloid leukemia. Transl Cancer Res 12(12):3693. https:\/\/doi.org\/10.21037\/tcr-23-429","journal-title":"Transl Cancer Res"},{"issue":"3","key":"6616_CR49","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/cam4.4487","volume":"11","author":"R Li","year":"2022","unstructured":"Li R, Wu S, Wu X, Zhao P, Li J, Xue K (2022) Immune\u2010relatedlncrnas can predict the prognosis of acute myeloid leukemia. Cancer Med 11(3):888. https:\/\/doi.org\/10.1002\/cam4.4487","journal-title":"Cancer Med"},{"key":"6616_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1203345","volume":"14","author":"J Xue","year":"2023","unstructured":"Xue J, Chen H, Lu J, Zhang H, Geng J, He P et al (2023) Identification of immunity-related lncRNAs and construction of a ceRNA network of potential prognostic biomarkers in acute myeloid leukemia. Front Genet 14:1203345. https:\/\/doi.org\/10.3389\/fgene.2023.1203345","journal-title":"Front Genet"},{"issue":"8","key":"6616_CR51","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1007\/s10238-023-01085-2","volume":"23","author":"X Liang","year":"2023","unstructured":"Liang X, Li C, Fan M, Zhang W, Liu L, Zhou J et al (2023) Immune-related lncRNAs pairs prognostic score model for prediction of survival in acute myeloid leukemia patients. Clin Exp Med 23(8):4527\u201338. https:\/\/doi.org\/10.1007\/s10238-023-01085-2","journal-title":"Clin Exp Med"},{"issue":"9","key":"6616_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30616","volume":"10","author":"M Zhang","year":"2024","unstructured":"Zhang M, Zhang LL, Yi LB, Tu XN, Zhou Y, Li DY et al (2024) Comprehensive analysis of immune-related lncRNAs in AML patients uncovers potential therapeutic targets and prognostic biomarkers. Heliyon 10(9):e30616. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30616","journal-title":"Heliyon"},{"issue":"1","key":"6616_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05797-5","volume":"12","author":"F Zhong","year":"2022","unstructured":"Zhong F, Yao F, Cheng Y, Liu J, Zhang N, Li S et al (2022) M6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia. Sci Rep 12(1):1759. https:\/\/doi.org\/10.1038\/s41598-022-05797-5","journal-title":"Sci Rep"},{"key":"6616_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.770451","volume":"9","author":"D Li","year":"2021","unstructured":"Li D, Liang J, Cheng C, Guo W, Li S, Song W et al (2021) Identification of m6A-related lncRNAs associated with prognoses and immune responses in acute myeloid leukemia. Front Cell Dev Biol 9:770451. https:\/\/doi.org\/10.3389\/fcell.2021.770451","journal-title":"Front Cell Dev Biol"},{"key":"6616_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.804614","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Ke W, Hu P, Li Z, Geng W, Guo Y et al (2022) N6-methyladenosine-related lncRNAs are novel prognostic markers and predict the immune landscape in acute myeloid leukemia. Front Genet 13:804614. https:\/\/doi.org\/10.3389\/fgene.2022.804614","journal-title":"Front Genet"},{"issue":"1","key":"6616_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2231760","volume":"28","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Jian J, Niu Y, Yang X, Guo Y, Zhao L et al (2023) Construction and validation of an NAD\u2009+\u2009metabolism-related lncRNA signature for predicting the prognosis and immune landscape of acute myeloid leukemia. Hematology 28(1):2231760. https:\/\/doi.org\/10.1080\/16078454.2023.2231760","journal-title":"Hematology"},{"issue":"4","key":"6616_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2022.103347","volume":"70","author":"J Xie","year":"2022","unstructured":"Xie J, Chen K, Han H, Dong Q, Wang W (2022) Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia. Curr Res Transl Med 70(4):103347. https:\/\/doi.org\/10.1016\/j.retram.2022.103347","journal-title":"Curr Res Transl Med"},{"key":"6616_CR58","doi-asserted-by":"publisher","unstructured":"Zhong G, Guo C, Shang Y, Cui Z, Zhou M, Sun M et al (2022) Development of a novel pyroptosis-related LncRNA signature with multiple significance in acute myeloid leukemia. Front Genet 13:1029717. https:\/\/doi.org\/10.3389\/fgene.2022.1029717","DOI":"10.3389\/fgene.2022.1029717"},{"issue":"1","key":"6616_CR59","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/16078454.2022.2056677","volume":"27","author":"Q Xu","year":"2022","unstructured":"Xu Q, Guo T (2022) Somatic mutation-associated risk index based on lncRNA expression for predicting prognosis in acute myeloid leukemia. Hematology 27(1):659\u201371. https:\/\/doi.org\/10.1080\/16078454.2022.2056677","journal-title":"Hematology"},{"issue":"8","key":"6616_CR60","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3324\/haematol.2017.166215","volume":"102","author":"D Papaioannou","year":"2017","unstructured":"Papaioannou D, Nicolet D, Volinia S, Mrozek K, Yan P, Bundschuh R et al (2017) Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia. Haematologica 102(8):1391\u2013400. https:\/\/doi.org\/10.3324\/haematol.2017.166215","journal-title":"Haematologica"},{"issue":"2","key":"6616_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/cas.13465","volume":"109","author":"Y Feng","year":"2018","unstructured":"Feng Y, Shen Y, Chen H, Wang X, Zhang R, Peng Y et al (2018) Expression profile analysis of long non\u2010coding <scp>RNA<\/scp>in acute myeloid leukemia by microarray and bioinformatics. Cancer Sci 109(2):340\u201353. https:\/\/doi.org\/10.1111\/cas.13465","journal-title":"Cancer Sci"},{"key":"6616_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.106261","volume":"88","author":"H Zeng","year":"2020","unstructured":"Zeng H, Wu H, Yan M, Tang L, Guo X, Zhao X (2020) Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia. Leuk Res 88:106261. https:\/\/doi.org\/10.1016\/j.leukres.2019.106261","journal-title":"Leuk Res"},{"issue":"2","key":"6616_CR63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/leu.2017.210","volume":"32","author":"D Beck","year":"2018","unstructured":"Beck D, Thoms JAI, Palu C, Herold T, Shah A, Olivier J et al (2018) A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients. Leukemia 32(2):263\u201372. https:\/\/doi.org\/10.1038\/leu.2017.210","journal-title":"Leukemia"},{"key":"6616_CR64","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ebiom.2019.01.022","volume":"40","author":"CH Tsai","year":"2019","unstructured":"Tsai CH, Yao CY, Tien FM, Tang JL, Kuo YY, Chiu YC et al (2019) Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. EBioMedicine 40:240\u201350. https:\/\/doi.org\/10.1016\/j.ebiom.2019.01.022","journal-title":"EBioMedicine"},{"key":"6616_CR65","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.12659\/MSM.917182","volume":"25","author":"P Tang","year":"2019","unstructured":"Tang P, Xie M, Wei Y, Xie X, Chen D, Jiang Z (2019) A 10-long non-coding RNA-based expression signature as a potential biomarker for prognosis of acute myeloid leukemia. Med Sci Monit 25:4999\u20135004. https:\/\/doi.org\/10.12659\/MSM.917182","journal-title":"Med Sci Monit"},{"key":"6616_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.888173","volume":"13","author":"G Zheng","year":"2022","unstructured":"Zheng G, Liu M, Chang X, Cao X, Dong A, Zhu H et al (2022) Comprehensive analysis of N6-methyladenosine-related long noncoding RNA prognosis of acute myeloid leukemia and immune cell infiltration. Front Genet 13:888173. https:\/\/doi.org\/10.3389\/fgene.2022.888173","journal-title":"Front Genet"},{"issue":"16","key":"6616_CR67","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/JCO.22.01114","volume":"41","author":"JE Farrar","year":"2023","unstructured":"Farrar JE, Smith JL, Othus M, Huang BJ, Wang YC, Ries R et al (2023) Long noncoding RNA expression independently predicts outcome in pediatric acute myeloid leukemia. J Clin Oncol 41(16):2949\u201362. https:\/\/doi.org\/10.1200\/JCO.22.01114","journal-title":"J Clin Oncol"},{"key":"6616_CR68","doi-asserted-by":"publisher","unstructured":"Wang F, Tian X, Zhou J, Wang G, Yu W, Li Z et al (2018) A three\u2013lncRNA signature for prognosis prediction of acute myeloid leukemia in patients. Mol Med Rep 18(2):1473\u201384. https:\/\/doi.org\/10.3892\/mmr.2018.9139","DOI":"10.3892\/mmr.2018.9139"},{"issue":"12","key":"6616_CR69","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1182\/bloodadvances.2024012667","volume":"8","author":"Z Ren","year":"2024","unstructured":"Ren Z, Vanhooren J, Derpoorter C, De Moerloose B, Lammens T (2024) A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML. Blood Adv 8(12):3299\u2013310. https:\/\/doi.org\/10.1182\/bloodadvances.2024012667","journal-title":"Blood Adv"},{"issue":"1","key":"6616_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00553-6","volume":"8","author":"F Markowetz","year":"2024","unstructured":"Markowetz F (2024) All models are wrong and yours are useless: making clinical prediction models impactful for patients. NPJ Precis Oncol 8(1):54. https:\/\/doi.org\/10.1038\/s41698-024-00553-6","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"6616_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","volume":"14","author":"CL Ramspek","year":"2021","unstructured":"Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M (2021) External validation of prognostic models: what, why, how, when and where? Clin Kidney J 14(1):49\u201358. https:\/\/doi.org\/10.1093\/ckj\/sfaa188","journal-title":"Clin Kidney J"},{"key":"6616_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-16399-0","volume-title":"Clinical prediction models: A practical approach to development, validation, and updating","author":"EW Steyerberg","year":"2019","unstructured":"Steyerberg EW (2019) Clinical prediction models: A practical approach to development, validation, and updating. Springer, New York"},{"key":"6616_CR73","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.omtn.2023.03.004","volume":"32","author":"MR Khan","year":"2023","unstructured":"Khan MR, Avino M, Wellinger RJ, Laurent B (2023) Distinct regulatory functions and biological roles of lncRNA splice variants. Mol Ther 32:127\u201343. https:\/\/doi.org\/10.1016\/j.omtn.2023.03.004","journal-title":"Mol Ther"},{"issue":"6","key":"6616_CR74","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL et al (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24(6):430\u201347. https:\/\/doi.org\/10.1038\/s41580-022-00566-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6616_CR75","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.csbj.2020.06.014","volume":"18","author":"G Deschamps-Francoeur","year":"2020","unstructured":"Deschamps-Francoeur G, Simoneau J, Scott MS (2020) Handling multi-mapped reads in RNA-seq. Comput Struct Biotechnol J 18:1569\u201376. https:\/\/doi.org\/10.1016\/j.csbj.2020.06.014","journal-title":"Comput Struct Biotechnol J"},{"key":"6616_CR76","doi-asserted-by":"publisher","unstructured":"Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A et al (2016) A survey of best practices for RNA-seq data analysis. Genome Biol 17:13. https:\/\/doi.org\/10.1186\/s13059-016-0881-8","DOI":"10.1186\/s13059-016-0881-8"},{"issue":"1","key":"6616_CR77","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14737140.2021.1841640","volume":"21","author":"AE Hoffman","year":"2021","unstructured":"Hoffman AE, Schoonmade LJ, Kaspers GJ (2021) Pediatric relapsed acute myeloid leukemia: a systematic review. Expert Rev Anticancer Ther 21(1):45\u201352. https:\/\/doi.org\/10.1080\/14737140.2021.1841640","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"6616_CR78","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1158\/0008-5472.CAN-15-3284","volume":"76","author":"YZ Jiang","year":"2016","unstructured":"Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu KD et al (2016) Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value. Cancer Res 76(8):2105\u201314. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3284","journal-title":"Cancer Res"},{"key":"6616_CR79","doi-asserted-by":"publisher","unstructured":"He M, Jiang YZ, Gong Y, Fan L, Liu XY, Liu Y et al (2024) Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial. BMJ 387:e079603. https:\/\/doi.org\/10.1136\/bmj-2024-079603","DOI":"10.1136\/bmj-2024-079603"},{"issue":"8","key":"6616_CR80","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27(8):1160\u20137. https:\/\/doi.org\/10.1200\/JCO.2008.18.1370","journal-title":"J Clin Oncol"},{"key":"6616_CR81","doi-asserted-by":"publisher","unstructured":"Goytain A, Ng T (2020) NanoString nCounter Technology: High-throughput RNA validation. Methods Mol Biol 2079:125\u2013\u20099. https:\/\/doi.org\/10.1007\/978-1-4939-9904-0_10","DOI":"10.1007\/978-1-4939-9904-0_10"},{"issue":"8","key":"6616_CR82","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1535-7163.MCT-18-1125","volume":"18","author":"D Papaioannou","year":"2019","unstructured":"Papaioannou D, Nicolet D, Ozer HG, Mrozek K, Volinia S, Fadda P et al (2019) Prognostic and biologic relevance of clinically applicable long noncoding RNA profiling in older patients with cytogenetically normal acute myeloid leukemia. Mol Cancer Ther 18(8):1451\u20139. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-1125","journal-title":"Mol Cancer Ther"},{"key":"6616_CR83","doi-asserted-by":"publisher","unstructured":"Liu MC, Pitcher BN, Mardis ER, Davies SR, Friedman PN, Snider JE et al (2016) PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance). NPJ Breast Cancer 2:15023-. https:\/\/doi.org\/10.1038\/npjbcancer.2015.23","DOI":"10.1038\/npjbcancer.2015.23"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06616-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:30:09Z","timestamp":1761283809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06616-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6616"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06616-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}